Prevalence of priapism in children and adolescents with sickle cell anemia

Elpis Mantadakis, Joe Don Cavender, Zora R. Rogers, David H. Ewalt, George R. Buchanan

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

A questionnaire survey was conducted of patients with homozygous sickle cell anemia (Hb SS) and sickle cell β0-thalassemia (Hb S-β0) between 5 and 20 years of age to determine the prevalence and characteristics (number of episodes, timing, duration, cause, or precipitating event) of priapism. Ninety-eight male patients or their parents were surveyed by the same male investigator using a structured verbal interview, which was modified according to the age of the patient. Ninety-four patients had Hb SS and four Hb S-β0 thalassemia. Eleven (11%) patients were known to have experienced priapism previously. In response to the questionnaire, 16 of the remaining 87 (18%) patients reported having had priapism on one or more occasions. The actuarial probability of experiencing priapism by 20 years of age was 89% (± 9%). The mean age at the initial episode was 12 years, the mean number of episodes per patient was 15.7 (median, 1; range, 1-100), and the mean duration of an episode was 125 minutes. Episodes typically occurred around 4:00 am, and 75% of the patients surveyed had at least one episode starting during sleep or upon awakening from sleep. The prevalence of priapism in children and adolescents with SCA is much higher than previously described. Since early intervention and treatment may prevent irreversible penile fibrosis and impotence, patients and parents should be educated about this complication in advance of its occurrence.

Original languageEnglish (US)
Pages (from-to)518-522
Number of pages5
JournalJournal of Pediatric Hematology/Oncology
Volume21
Issue number6
DOIs
StatePublished - Nov 1999

Fingerprint

Priapism
Sickle Cell Anemia
Thalassemia
Sleep
Parents
Erectile Dysfunction
Fibrosis
Research Personnel
Interviews

Keywords

  • Homozygous sickle cell anemia
  • Prevalence
  • Priapism
  • Sickle cell β-thalassemia
  • Sickle cell anemia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Prevalence of priapism in children and adolescents with sickle cell anemia. / Mantadakis, Elpis; Cavender, Joe Don; Rogers, Zora R.; Ewalt, David H.; Buchanan, George R.

In: Journal of Pediatric Hematology/Oncology, Vol. 21, No. 6, 11.1999, p. 518-522.

Research output: Contribution to journalArticle

@article{2cd0eb5969d44fff810b9d7ddf91fd42,
title = "Prevalence of priapism in children and adolescents with sickle cell anemia",
abstract = "A questionnaire survey was conducted of patients with homozygous sickle cell anemia (Hb SS) and sickle cell β0-thalassemia (Hb S-β0) between 5 and 20 years of age to determine the prevalence and characteristics (number of episodes, timing, duration, cause, or precipitating event) of priapism. Ninety-eight male patients or their parents were surveyed by the same male investigator using a structured verbal interview, which was modified according to the age of the patient. Ninety-four patients had Hb SS and four Hb S-β0 thalassemia. Eleven (11{\%}) patients were known to have experienced priapism previously. In response to the questionnaire, 16 of the remaining 87 (18{\%}) patients reported having had priapism on one or more occasions. The actuarial probability of experiencing priapism by 20 years of age was 89{\%} (± 9{\%}). The mean age at the initial episode was 12 years, the mean number of episodes per patient was 15.7 (median, 1; range, 1-100), and the mean duration of an episode was 125 minutes. Episodes typically occurred around 4:00 am, and 75{\%} of the patients surveyed had at least one episode starting during sleep or upon awakening from sleep. The prevalence of priapism in children and adolescents with SCA is much higher than previously described. Since early intervention and treatment may prevent irreversible penile fibrosis and impotence, patients and parents should be educated about this complication in advance of its occurrence.",
keywords = "Homozygous sickle cell anemia, Prevalence, Priapism, Sickle cell β-thalassemia, Sickle cell anemia",
author = "Elpis Mantadakis and Cavender, {Joe Don} and Rogers, {Zora R.} and Ewalt, {David H.} and Buchanan, {George R.}",
year = "1999",
month = "11",
doi = "10.1097/00043426-199911000-00014",
language = "English (US)",
volume = "21",
pages = "518--522",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Prevalence of priapism in children and adolescents with sickle cell anemia

AU - Mantadakis, Elpis

AU - Cavender, Joe Don

AU - Rogers, Zora R.

AU - Ewalt, David H.

AU - Buchanan, George R.

PY - 1999/11

Y1 - 1999/11

N2 - A questionnaire survey was conducted of patients with homozygous sickle cell anemia (Hb SS) and sickle cell β0-thalassemia (Hb S-β0) between 5 and 20 years of age to determine the prevalence and characteristics (number of episodes, timing, duration, cause, or precipitating event) of priapism. Ninety-eight male patients or their parents were surveyed by the same male investigator using a structured verbal interview, which was modified according to the age of the patient. Ninety-four patients had Hb SS and four Hb S-β0 thalassemia. Eleven (11%) patients were known to have experienced priapism previously. In response to the questionnaire, 16 of the remaining 87 (18%) patients reported having had priapism on one or more occasions. The actuarial probability of experiencing priapism by 20 years of age was 89% (± 9%). The mean age at the initial episode was 12 years, the mean number of episodes per patient was 15.7 (median, 1; range, 1-100), and the mean duration of an episode was 125 minutes. Episodes typically occurred around 4:00 am, and 75% of the patients surveyed had at least one episode starting during sleep or upon awakening from sleep. The prevalence of priapism in children and adolescents with SCA is much higher than previously described. Since early intervention and treatment may prevent irreversible penile fibrosis and impotence, patients and parents should be educated about this complication in advance of its occurrence.

AB - A questionnaire survey was conducted of patients with homozygous sickle cell anemia (Hb SS) and sickle cell β0-thalassemia (Hb S-β0) between 5 and 20 years of age to determine the prevalence and characteristics (number of episodes, timing, duration, cause, or precipitating event) of priapism. Ninety-eight male patients or their parents were surveyed by the same male investigator using a structured verbal interview, which was modified according to the age of the patient. Ninety-four patients had Hb SS and four Hb S-β0 thalassemia. Eleven (11%) patients were known to have experienced priapism previously. In response to the questionnaire, 16 of the remaining 87 (18%) patients reported having had priapism on one or more occasions. The actuarial probability of experiencing priapism by 20 years of age was 89% (± 9%). The mean age at the initial episode was 12 years, the mean number of episodes per patient was 15.7 (median, 1; range, 1-100), and the mean duration of an episode was 125 minutes. Episodes typically occurred around 4:00 am, and 75% of the patients surveyed had at least one episode starting during sleep or upon awakening from sleep. The prevalence of priapism in children and adolescents with SCA is much higher than previously described. Since early intervention and treatment may prevent irreversible penile fibrosis and impotence, patients and parents should be educated about this complication in advance of its occurrence.

KW - Homozygous sickle cell anemia

KW - Prevalence

KW - Priapism

KW - Sickle cell β-thalassemia

KW - Sickle cell anemia

UR - http://www.scopus.com/inward/record.url?scp=0033503423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033503423&partnerID=8YFLogxK

U2 - 10.1097/00043426-199911000-00014

DO - 10.1097/00043426-199911000-00014

M3 - Article

C2 - 10598664

AN - SCOPUS:0033503423

VL - 21

SP - 518

EP - 522

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 6

ER -